Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

3 Reasons to Buy Medtronic Stock
3 Reasons to Buy Medtronic Stock

Medical device specialist Medtronic (NYSE: MDT) has not been the best of investments over the past five years. The stock has significantly lagged the market over this period, thanks to weak business

Why Is UnitedHealth Stock Falling, and Is It a Buying Opportunity?
Why Is UnitedHealth Stock Falling, and Is It a Buying Opportunity?

UnitedHealth (NYSE: UNH) revised its annual targets, disappointing stock market investors.

*Stock prices used were the afternoon prices of July 28, 2025. The video was published on July 30, 2025.

Stryker (SYK) Q2 Revenue Jumps 11%
Stryker (SYK) Q2 Revenue Jumps 11%

Stryker (NYSE:SYK), a leading global medical technology company, reported financial results on July 31, 2025. The company delivered several key beats: Net sales (GAAP) reached $6.0 billion, topping

Cigna (CI) Q2 Revenue Jumps 11%
Cigna (CI) Q2 Revenue Jumps 11%

Cigna Group (NYSE:CI), a global health services company offering integrated medical, pharmacy, and specialty care solutions, released its second-quarter earnings on July 31, 2025. The company

Genesis Energy (GEL) Q2 Revenue Down 12%
Genesis Energy (GEL) Q2 Revenue Down 12%

Genesis Energy (NYSE:GEL), a midstream energy infrastructure company focused on pipeline and transportation services in the Gulf of America, reported its second quarter 2025 earnings on July 31

iRhythm (IRTC) Q2 Revenue Jumps 26%
iRhythm (IRTC) Q2 Revenue Jumps 26%

iRhythm Technologies (NASDAQ:IRTC), a medical device company specializing in cardiac monitoring technology, reported its Q2 FY2025 results on July 31, 2025. The highlight was record revenue (GAAP)

Glaukos (GKOS) Q2 Revenue Jumps 30%
Glaukos (GKOS) Q2 Revenue Jumps 30%

Glaukos (NYSE:GKOS), a medical technology company focused on novel ophthalmic therapies, announced its financial results for the second quarter on July 30, 2025. The company reported GAAP revenue of

DexCom (DXCM) Q2 Revenue Jumps 15%
DexCom (DXCM) Q2 Revenue Jumps 15%

DexCom (NASDAQ:DXCM) reported its second-quarter 2025 results on July 30, 2025, delivering an upbeat performance highlighted by a revenue beat and continued expansion in the key type 2 diabetes

Integra (IART) Q2 Revenue Beats by 5%
Integra (IART) Q2 Revenue Beats by 5%

Integra LifeSciences (NASDAQ:IART), a medical technology company specializing in neurosurgery, reconstructive, and tissue technologies, released its results for Q2 2025 on July 31, 2025. The most

Illumina: A 5.2 Rating Amid Challenges and Opportunities
Illumina: A 5.2 Rating Amid Challenges and Opportunities

Explore the exciting world of Illumina (NASDAQ: ILMN) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

Security Federal (SFDL) Q2 EPS Jumps 14%
Security Federal (SFDL) Q2 EPS Jumps 14%

Security Federal (OTC:SFDL), a regional bank focused on retail and commercial banking across South Carolina and Georgia, released its earnings for the quarter ended June 30, 2025, on July 30, 2025

Hologic (HOLX) Q3 Revenue Beats 1%
Hologic (HOLX) Q3 Revenue Beats 1%

Hologic (NASDAQ:HOLX), a global medical technology company specializing in diagnostics and women’s health, reported financial results for the third quarter of fiscal 2025 on July 30, 2025. The most

An Unpopular Pick: 5 Reasons Why Buying UnitedHealth Group Stock Now Could Be a Brilliant Move
An Unpopular Pick: 5 Reasons Why Buying UnitedHealth Group Stock Now Could Be a Brilliant Move

An old country song morbidly titled "Gloom, Despair, and Agony on Me" included the lyrics, "If it weren't for bad luck, I'd have no luck at all." This might be an apt motto for UnitedHealth Group

Amedisys (AMED) Q2 Revenue Tops 5%
Amedisys (AMED) Q2 Revenue Tops 5%

Amedisys (NASDAQ:AMED), a leading provider of home health, hospice, and high acuity post-acute care services, reported quarterly earnings for the period ending June 30, 2025, on July 29, 2025. The

Penumbra (PEN) Q2 Revenue Jumps 13%
Penumbra (PEN) Q2 Revenue Jumps 13%

Penumbra (NYSE:PEN), a medical device innovator focused on clot removal and vascular care, reported its second quarter 2025 results on July 29, 2025. The company delivered $339.5 million in GAAP

AtriCure (ATRC) Q2 Revenue Jumps 17%
AtriCure (ATRC) Q2 Revenue Jumps 17%

AtriCure (NASDAQ:ATRC), a medical device company specializing in cardiac surgical technologies, delivered its earnings release on July 29, 2025, reporting results that outpaced Wall Street consensus

Why Chemed Stock Is Plummeting Today
Why Chemed Stock Is Plummeting Today

Chemed (NYSE: CHE) -- home to hospice care provider Vitas Healthcare and Roto-Rooter -- saw its shares decline 9% as of 1 p.m. ET on Wednesday, according to data provided by S&P Global Market

UnitedHealth Group Posts Q2 Revenue Gain
UnitedHealth Group Posts Q2 Revenue Gain

UnitedHealth Group (NYSE:UNH), a leading diversified healthcare and insurance provider, reported results for the second quarter of fiscal 2025 on July 29, 2025. The most significant news was its

EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years
AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland confirms its growth momentum in the first half of 2025 and improves profitability
AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland confirms its growth momentum in the first half of 2025 and improves profitability
AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland confirms its growth momentum in the first half of 2025 and improves profitability
Ameris Bancorp Posts 36% EPS Jump in Q2
Ameris Bancorp Posts 36% EPS Jump in Q2

Ameris Bancorp (NYSE:ABCB), a regional banking company with a strong presence in the Southeast, reported results for Q2 2025 on July 28, 2025. The most notable headline was a beat on non-GAAP

UnitedHealth Stock Is Having Its Worst Year Since 2008. Can It Recover?
UnitedHealth Stock Is Having Its Worst Year Since 2008. Can It Recover?

For years UnitedHealth Group (NYSE: UNH) has normally been a reliable dividend stock. But an abysmal start to 2025 has wiped out many of the gains that investors have achieved in recent years, with

Boston Sci Q2 Revenue Up 23%
Boston Sci Q2 Revenue Up 23%

Boston Scientific (NYSE:BSX), a leading medical device maker known for its heart and surgical products, released second-quarter results on July 23, 2025. Revenue reached $5.06 billion for Q2 2025

Pacific Premier Posts Q2 Profit Drop
Pacific Premier Posts Q2 Profit Drop

Pacific Premier Bancorp (NASDAQ:PPBI), a commercial bank focused on business and specialty lending across the western United States, released its Q2 2025 financial results on July 24, 2025. The

Should You Buy UnitedHealth Before July 29?
Should You Buy UnitedHealth Before July 29?

In this video, I will talk about UnitedHealth Group (NYSE: UNH) and why buying the stock before it reports earnings could make sense. Watch the short video to learn more, consider subscribing, and